A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation - Quiz - MDSpire

A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation

  • By

  • Chenlu Hou

  • Yifan Zhang

  • Xiangqi Cao

  • Yonglan Tang

  • Ting Gao

  • Baoli Tang

  • Ying Zhu

  • Zhe Ruan

  • Ting Chang

  • June 3, 2026

  • 0 min

Share

Original Source(s)

A predictive model for low-dose rituximab response in anti-acetylcholine receptor antibody-positive myasthenia gravis: establishment and validation

  • by Chenlu Hou, Yifan Zhang, Xiangqi Cao, Yonglan Tang, Ting Gao, Baoli Tang, Ying Zhu, Zhe Ruan, Ting Chang

  • June 3, 2026

Related Content

“Homicide and Zonisamide”: a review of the literature and illustrative case report on second and third generation antiseizure medications and psychiatric effects

Editorial: Mechanisms of functional dizziness: a window for understanding space-motion cognition

Spinal and supraspinal mechanisms of chronic itch: from neuronal circuits to the neuro-immune-microbial axis